an-effective-treatment-against-the-most-common-skin-tumor-in-seniors?

An effective treatment for “the most common skin tumor” in seniors?

February 7, 2025

news

By Julie from Coucy THE Subscribers

Austrian researchers have conducted a promising clinical trial of TVEC, an oncolytic virus used against skin cancer. In phase II, it reduced the size of basal cell carcinomas in all patients. For Science and Future, Eve Maubec, a carcinoma specialist, deciphers the progress of this work.

tatenda-mawoyo-and-stefani-du-toit-are-odd3-researchers
Read moreTatenda Mawoyo and Stefani du Toit are SDG3 researchers

A dermatologist examines the skin.

Basal cell carcinoma may recur locally in 1 to 8% cases and further surgery must then be proposed.

MICROGEN IMAGES/SCIENCE PHOTO LI / SMD / Science Photo Library via AFP

The results of a phase II clinical trial, published in the journal Nature Cancer, announce a promising advance in the treatment of basal cell carcinoma (BCC), the most common skin cancer in people over 60. Science and Future, Eve Maubec, professor of dermatology and secretary of the Cutaneous Cancerology Group of the French Society of Dermatology (SFD), analyses for Science and Future the scope of this study.

Sciences et Avenir: What are the current therapeutic options in the treatment of basal cell carcinoma?

Dermatology Carcinoma Skin cancer

“
»
en_USEnglish
fr_FRFrench en_USEnglish